|
|
HIV Update 2002 (3) - MarchPublished by: Datamonitor Published: Apr. 23, 2002 - 33 Pages Table of ContentsEXECUTIVE SUMMARY Key Market Events in March 2002 STRUCTURE OF UPDATE ANALYSIS OF KEY DEVELOPMENTS IN MARCH 2002 COMPANY HEADLINES Gilead Sales Force Overemphasizes Efficacy of Viread Withdrawal of BI’s Application for Use of Viramune in Pregnant Women $2 Million Awarded Towards Vaccine Research and Drug Discovery for Novel HIV Treatments, Favoring Small Companies PanaMed To Make HIV Therapeutic Bid Genetic Variations May Be Responsible for Hypersensitivity to Ziagen RESEARCH AND DEVELOPMENT HEADLINES Short Course AZT Decreases MTCT in HIV-Positive Pregnant Women Experimental Treatment of HAART-Experienced Patients with Ampligen Yields Promising Results Vaccine Adjunct Shown Effective at Improving Immune Response for HAART Treated Patients Two Novel HIV Compounds to be Tested at the Institute of Human Virology Cyclosporin A Improves HAART Treatment Outcome Following Primary HIV Infection Viramune Preferable to Retrovir in the Treatment of HIV-Positive Pregnant Women Immune Therapy Achieves Positive Trials for HIV New Adjuvant May Offer New Hope for HIV Vaccine Development Promising Dual PI Boosting Trials With Roche’s Fortovase Abacavir Proves Promising In Children DISEASE SPECIFIC HEADLINES Reduction of Vertical Transmission Through Treatment of Placental Inflammation Use of Cannabinoids Does Not Appear to Affect HAART Treatment Outcomes New Blood Test Monitors Mitochondrial Toxicity Cross-Resistance Against HIV Highest Amongst PIs and NNRTIs Persistence of Multiple-Drug Resistant HIV Strains in the Absence of Selective Antiretroviral Drug Pressure Latent HIV Infection Does Not Necessarily Induce an Altered Cell Phenotype Inconclusive Trial Results Over Myocardial Infarction Caused by PI Use Possible Cancer Role for PIs? HIV Treatment Interruptions May Increase Risk of Progression to AIDS EMERGING MARKETS HEADLINES South African High Court Overrules Government over Viramune Availability to HIV-Positive Pregnant Women APPENDIX Datamonitor's Infectious Disease Business Unit Research Background Contacts and Further Reading © Datamonitor 2002. All Rights Reserved. AbstractThis HIV monthly update provides an analysis of key HIV and AIDS market events that have occurred during March 2002. Sourced from extensive ongoing clinical and commercial journal review, and complemented through conference participation, physician interviews and Opinion Leader input, Datamonitor’s HIV Updates offer a definitive insight into the changing HIV market.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||